CA Patent

CA2790820A1 — Use (1s,3s)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid as a gaba aminotransferse inhibitor

Assigned to Brookhaven Science Associates LLC · Expires 2011-09-01 · 15y expired

What this patent protects

(1S,3S)-amino-4-difluoromethylenyl-1-cyclopentanoic acid also known as CPP-115 can be used to treat addiction and neurological disorders without side effects such as visual field defects caused by vigabatrin (Sabril).

USPTO Abstract

(1S,3S)-amino-4-difluoromethylenyl-1-cyclopentanoic acid also known as CPP-115 can be used to treat addiction and neurological disorders without side effects such as visual field defects caused by vigabatrin (Sabril).

Drugs covered by this patent

Patent Metadata

Patent number: CA2790820A1
Jurisdiction: CA
Classification: —
Expires: 2011-09-01
Drug substance claim: No
Drug product claim: No
Assignee: Brookhaven Science Associates LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.